SubHero Banner

Omidria® (phenylephrine/ketorolac) – Expanded indication

December 12, 2017 – Omeros announced the FDA approval of Omidria (phenylephrine/ketorolac), to include use in pediatric patients (ages birth through 17 years old) when added to an ocular irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

Download PDF